Vigilare Wealth Management Adaptive Biotechnologies Corp Transaction History

Vigilare Wealth Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 06, 2022	SELL	$10.12 - $28.9 $130,294 - $372,087	-12,875 Closed	0 $0
Q4 2021 Jan 07, 2022	BUY	$25.17 - $36.85 $87,465 - $128,053	3,475 Added 36.97%	12,875 $361,000
Q3 2021 Oct 19, 2021	BUY	$30.02 - $39.87 $10,507 - $13,954	350 Added 3.87%	9,400 $320,000
Q2 2021 Jul 16, 2021	BUY	$32.22 - $44.59 $60,251 - $83,383	1,870 Added 26.04%	9,050 $370,000
Q1 2021 Apr 29, 2021	BUY	$37.26 - $67.74 $267,526 - $486,373	7,180 New	7,180 $289,000
Q1 2020 May 04, 2020	SELL	$16.96 - $34.16 $130,592 - $263,032	-7,700 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$24.56 - $32.8 $189,112 - $252,559	7,700 New	7,700 $231,000

187

152M

8.4K

56K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $734M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Vigilare Wealth Management with notifications on news.